Heterogeneity_NN
of_IN
clonal_JJ
development_NN
in_IN
chronic_JJ
myeloproliferative_JJ
disorders_NNS
._.

Recent_JJ
reports_NNS
have_VBP
suggested_VBN
a_DT
previously_RB
unexpected_JJ
variability_NN
in_IN
the_DT
expression_NN
of_IN
the_DT
dominant_JJ
neoplastic_JJ
clone_NN
in_IN
myeloproliferative_JJ
disorders_NNS
-LRB-_-LRB-
MPD_NN
-RRB-_-RRB-
._.

We_PRP
evaluated_VBD
49_CD
female_JJ
patients_NNS
with_IN
MPD_NN
and_CC
informative_JJ
at_IN
the_DT
X-linked_JJ
androgen_NN
receptor_NN
-LRB-_-LRB-
AR_NN
-RRB-_-RRB-
locus_NN
to_TO
establish_VB
the_DT
X_NN
chromosome_NN
inactivation_NN
pattern_NN
of_IN
hemopoietic_JJ
cells_NNS
._.

Whereas_IN
in_IN
chronic_JJ
myelogenous_JJ
leukemia_NN
-LRB-_-LRB-
CML_NN
-RRB-_-RRB-
the_DT
granulocytes_NNS
-LRB-_-LRB-
PMN_NN
-RRB-_-RRB-
were_VBD
uniformly_RB
of_IN
monoclonal_JJ
origin_NN
,_,
a_DT
striking_JJ
heterogeneity_NN
of_IN
clonal_JJ
development_NN
was_VBD
found_VBN
in_IN
PMN_NN
from_IN
patients_NNS
with_IN
other_JJ
MPD_NN
,_,
with_IN
up_RB
to_TO
50_CD
%_NN
of_IN
them_PRP
expressing_VBG
a_DT
polyclonal_JJ
pattern_NN
of_IN
X_NN
inactivation_NN
._.

